AI assistant
Ambu — Share Issue/Capital Change 2014
Aug 29, 2014
3353_iss_2014-08-29_76941539-c365-4110-9324-5e5e13e148df.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Ambu A/S – Disclosure requirement concerning share capital
Under section 6 of the Danish Executive Order on disclosure requirements for issuers, Ambu A/S is to announce the total share capital of Ambu A/S by the end of a month in which any change of the share capital was effected.
The table below shows the total share capital of Ambu A/S as at 29 August 2014, see also company announcement no. 14, 2013/2014.
| Number of shares (nominal value DKK 10) |
Nominal value (DKK) |
|
|---|---|---|
| A shares | 1,716,000 | 17,160,000 |
| B shares | 10,227,580 | 102,275,800 |
Contact
Lars Marcher, President & CEO, tel. +45 5136 2490, email: [email protected]
Ambu A/S Baltorpbakken 13 DK-2750 Ballerup Tel. +45 7225 2000 CVR no.: 63 64 49 19 www.ambu.com
About Ambu
Since 1937, breakthrough ideas have driven our work to bring efficient healthcare solutions to life within our fields of excellence: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. Millions of patients and healthcare professionals worldwide depend and rely on the functionality and performance of our products. We are dedicated to improving patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our latest landmark solutions such as the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognised medico-technical companies in the world. Our head office is situated near Copenhagen in Denmark. Ambu employs approximately 2,250 people in Europe, North America, and the Asia Pacific. For more information, please visit www.ambu.com.